
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors is poised for long-term organic growth through its shift towards a more diverse portfolio consisting of primarily SHOP assets. The recent portfolio sale for $560 million will not only improve the company's growth profile but also reduce its net debt/EBITDA and provide funds for future acquisitions. Risks to the positive outlook include potential disruptions to government reimbursements and acquisition volumes/pricing, as well as the concentration of the company's operators. However, the company's strong management team and focus on senior housing and medical facilities make it a solid investment choice for those looking for stable and growing returns.
Bears say
National Health Investors is a high-quality real estate investment trust (REIT) that has consistently generated strong financial results in the past. However, there are several potential concerns that could impact the company's future performance. These include exposure to the skilled nursing industry, which has seen significant regulatory and reimbursement pressures in recent years, as well as the company's high dependence on one operator for a large portion of its revenue. Additionally, the pending departure of two board members and potential conflicts of interest with the company's relationship with NHC could also be a cause for concern. Overall, while National Health Investors has a strong track record, the current market conditions and potential risks make me cautious about the company's future prospects.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares